Current Pharmaceutical Design
Title: Editorial [Hot Topic: Cancer Cell Redox Status: Novel Target for Designing Strategies to Overcome Apoptosis Resistance (Executive Editor: S. Pervaiz)]
Volume: 12 Issue: 34
Author(s): Shazib Pervaiz
Affiliation:
Export Options
About this article
Cite this article as:
Pervaiz Shazib, Editorial [Hot Topic: Cancer Cell Redox Status: Novel Target for Designing Strategies to Overcome Apoptosis Resistance (Executive Editor: S. Pervaiz)], Current Pharmaceutical Design 2006; 12 (34) . https://dx.doi.org/10.2174/138161206779010521
DOI https://dx.doi.org/10.2174/138161206779010521 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Yin and Yang of Non-Neuronal α7-Nicotinic Receptors in Inflammation and Autoimmunity
Current Drug Targets Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Microneedle Patches as Drug and Vaccine Delivery Platform
Current Medicinal Chemistry Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?
Current Molecular Medicine Microbial Efflux Pump Inhibition: Tactics and Strategies
Current Pharmaceutical Design Antiproliferative Effects of Nerium oleander Stem and Mitotic Ar rest Induced by Cardenolide Odoroside B on NCI-H460 Cancer Cells
Letters in Drug Design & Discovery Vaccine Therapy of Melanoma: An Update
Current Cancer Therapy Reviews Regulation of Female Fertility and Identification of Future Contraceptive Targets
Current Pharmaceutical Design KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives
Current Molecular Medicine Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist
Protein & Peptide Letters Editorial: [Hot Topic: TGF-β1 in Pre-Malignant and Malignant Liver Disease]
Current Pharmaceutical Design Ionic Liquids for Topical Delivery in Cancer
Current Medicinal Chemistry Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Engineered Inorganic Nanoparticles for Drug Delivery Applications
Current Drug Metabolism Design, Synthesis and Anticancer Evaluation of Novel Series of Indibulin Analogues
Medicinal Chemistry Genetics and Molecular Biology of Tuberous Sclerosis Complex
Current Genomics Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Radiolabeled Compounds in the Development of Cytotoxic Agents
Current Pharmaceutical Design RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
Current Cancer Drug Targets